It is characterized by an autoimmune response against pancreatic islet antigens including insulin, which eventually leads to pancreatic β-cell depletion and, consequently, abolished insulin production resulting in hyperglycaemia [2]. The gene discussed is INS; the disease is Hyperglycemia.